TCL Archive High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I April 27, 2001
TCL Archive In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles November 4, 1983
TCL Archive DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs December 4, 1992
TCL Archive UCSF. Roswell Park Win National Cooperative Drug Discovery Group Awards; RFA To Be Reissued June 15, 1984